What's New?

OSCAR’s First Patent Application Filed in China


The first patent application of OSCAR, ‘Primers for detecting novel coronavirus SARS-CoV-2 and test kits, methods and applications thereof’, was filed to China National Intellectual Property Administration (CNIPA) on 27th March.

The project, led by OSCAR PIs Prof. Zhanfeng Cui and Prof. Wei Huang, was initiated in January when the COVID-19 outbreak started in Wuhan, China. Researchers were unable to return to China following the New Year and worked quickly to develop a quick, accurate and easy-to-use test for SARS-CoV-2. In just six weeks, OSCAR researchers and colleagues from the Department of Engineering Science at the University of Oxford achieved a working solution based on RT-LAMP technology, allowing results in only 30 minutes from sampling. The test does not require laboratory access, specialist equipment or highly trained operatives to perform, meaning it could potentially be used in a wider range of sittings such as clinics, airports and even homes.

OSCAR submitted the patent application only a few weeks after the technology had been validated with real clinical samples at Shenzhen Luohu People’s Hospital in China. Additional clinical tests are now underway in the UK.





Senior Research Scientist in Prof. Zhanfeng Cui and Hua Ye’s group, Dr. Hui Wang, co-published a new paper “ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation” in Gene: X.






Dr. Hui Wang

Senior Research Scientist